Search
RGX-111
go.drugbank.com/drugs/DB17632InvestigationalDeveloped by REGENXBIO Inc., it was investigated for the treatment of mucopolysaccharidosis Type I (MPS I).[L46666]
SM-1997
go.drugbank.com/drugs/DB18670Experimental[A261816] It is under investigation for the treatment of cutaneous sulfur mustard-induced injury.
Tulisokibart
go.drugbank.com/drugs/DB18719InvestigationalIt is being investigated for ulcerative colitis.
Besifovir dipivoxil
go.drugbank.com/drugs/DB05020InvestigationalBesifovir dipivoxil is a small-molecule orally available inhibitor of the HBV polymerase. The HBV polymerase is the enzyme that catalyzes the production of new RNA from the existing strand of RNA. Besifovir dipivoxil is believed to inhib...
XmAb 2513
go.drugbank.com/drugs/DB06324InvestigationalIt has been investigated for the treatment of hodgkin’s lymphoma.
Poloxalene
go.drugbank.com/drugs/DB11451InvestigationalVet approvedIt belongs to the family of Epoxides. These are compounds containing a cyclic ether with three ring atoms (one oxygen and two carbon atoms).
ONT-093
go.drugbank.com/drugs/DB14069ExperimentalIn pre-clinical studies, ONT-093 could inhibit P-gp and reverse multidrug resistance at nM concentrations with no effect on paclitaxel pharmacokinetics.
Ravagalimab
go.drugbank.com/drugs/DB16676InvestigationalRavagalimab is under investigation in clinical trial NCT03695185 (A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe It Is in Participants With Moderate to Severe Ulcerative Colitis
Red blood cell-encapsulated L-asparaginase
go.drugbank.com/drugs/DB17477InvestigationalIt is being investigated in cancers.[L44923]